Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis
Titel:
Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis
Auteur:
Tricco, Andrea C Antony, Jesmin Soobiah, Charlene Hemmelgarn, Brenda Moher, David Hutton, Brian Yu, Catherine H Majumdar, Sumit R Straus, Sharon E